Abstract

Managing pediatric febrile seizures progressing into status epilepticus (SE) presents challenges due to diagnostic complexities and the evolving nature of symptoms. This case report presents the management of a 1-year-old pediatric patient who experienced a febrile seizure progressing into SE. Laboratory findings reflected common variations observed in febrile illnesses and seizures. Treatment comprised a multidrug regimen involving antibiotics, anticonvulsants, and supportive care, primarily focused on seizure control, infection management, and symptomatic relief, aligning with established protocols for SE management in pediatric patients. However, the potential for drug interactions, particularly with carbapenems, underscores the importance of medication selection, especially in patients predisposed to seizures or neurological complications. This case report emphasizes the necessity for a multidisciplinary approach involving pediatricians, neurologists, and clinical pharmacists in optimizing treatment strategies for SE. The involvement of clinical pharmacists in medication review, dosage adjustments, monitoring for drug interactions, and patient education played a pivotal role in achieving positive outcomes in this critical scenario. This report sheds light on the complexities and challenges inherent in managing pediatric febrile seizures advancing to SE and underscores the significance of collaborative, multidisciplinary care in such cases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.